Schatzman Randall C has filed 3 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 654000 shares of Bolt Biotherapeutics, Inc. ($BOLT) on March 04, 2024.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 4, 2024 | Bolt Biotherapeutics, Inc. | $BOLT | Schatzman Randall C | Chief Executive Officer | A | Stock Option (Right to Buy) | 654000 | $0.00 | 235,000.0000 | 0 | 0.00% | 0.00% |
| June 6, 2023 | Bolt Biotherapeutics, Inc. | $BOLT | Schatzman Randall C | Chief Executive Officer | P | Common Stock | 2500 | $1.18 | 10,359.0000 | 0 | 31.81% | 0.00% |
| Dec. 6, 2023 | Bolt Biotherapeutics, Inc. | $BOLT | Schatzman Randall C | Chief Executive Officer | P | Common Stock | 2500 | $0.78 | 12,859.0000 | 0 | 24.13% | 0.00% |